Provided by Tiger Fintech (Singapore) Pte. Ltd.

Myriad Genetics

8.88
-0.3400-3.69%
Post-market: 9.050.1700+1.91%18:06 EDT
Volume:599.37K
Turnover:5.32M
Market Cap:810.82M
PE:-6.30
High:9.43
Open:9.23
Low:8.70
Close:9.22
Loading ...

Myriad Genetics Inc - Q4 2024 Revenue of $211 Million, up 7% YoY

THOMSON REUTERS
·
25 Feb

Myriad Genetics Inc: Q4 Loss per Share $0.47

THOMSON REUTERS
·
25 Feb

Myriad Genetics Q4 Gross Margin 71.7%

THOMSON REUTERS
·
25 Feb

Myriad Genetics Q4 Operating Expenses USD 189.9 Million

THOMSON REUTERS
·
25 Feb

Myriad Genetics Inc - Appoints SAM Raha as President and CEO

THOMSON REUTERS
·
25 Feb

Myriad Genetics Inc - Paul J. Diaz Steps Down as CEO

THOMSON REUTERS
·
25 Feb

Myriad Genetics Announces Senior Leadership Transition

THOMSON REUTERS
·
25 Feb

Myriad Genetics Announces Senior Leadership Transition

GlobeNewswire
·
25 Feb

Myriad Genetics Reports Fourth Quarter and Full-Year 2024 Financial Results; Full-year 2024 revenue of $838 million grew 11% year-over-year, the second consecutive year of double-digit revenue growth

GlobeNewswire
·
25 Feb

Stock Track | Myriad Genetics Plunges 6.56% in Pre-Market on Licensing Deal with PATHOMIQ

Stock Track
·
24 Feb

Myriad Genetics Partners with PATHOMIQ to add Artificial Intelligence Technology Platform to its Oncology Portfolio

GlobeNewswire
·
24 Feb

What To Expect From Myriad Genetics’s (MYGN) Q4 Earnings

StockStory
·
23 Feb

Myriad Genetics Included in Forbes America’s Best Employers 2025 List

GlobeNewswire
·
19 Feb

Myriad Genetics to Release Fourth Quarter and Full Year 2024 Financial Results on February 24, 2025

GlobeNewswire
·
18 Feb

3 Reasons to Sell MYGN and 1 Stock to Buy Instead

StockStory
·
17 Feb

Insiders Sold US$6.5m Of Myriad Genetics Stock Possibly Sending Warning Sign

Simply Wall St.
·
15 Feb